Related references
Note: Only part of the references are listed.Outcome after discontinuation of infliximab in patients with inflammatory bowel disease in clinical remission: an observational Danish single center study
Casper Steenholdt et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee
Asher Kornbluth et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis
J. N. Hoes et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Erythrocyte-Mediated Delivery of Dexamethasone in Patients With Mild-to-Moderate Ulcerative Colitis, Refractory to Mesalamine: A Randomized, Controlled Study
Fabrizio Bossa et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Risk factors for opportunistic infections in patients with inflammatory bowel disease
Murat Toruner et al.
GASTROENTEROLOGY (2008)
European evidence-based Consensus on the management of ulcerative colitis: Current management
S. P. L. Travis et al.
JOURNAL OF CROHNS & COLITIS (2008)
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
E. F. Stange et al.
JOURNAL OF CROHNS & COLITIS (2008)
Tolerability and safety of mercaptopurine in azathioprine-intolerant patients with inflammatory bowel disease
C. W. Lees et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Inflammatory bowel disease: Progress and current concepts of etiopathogenesis
Franco Scaldaferri et al.
JOURNAL OF DIGESTIVE DISEASES (2007)
Long-term treatment with autologous red blood cells loaded with dexamethasone 21-phosphate in pediatric patients affected by steroid-dependent Crohn disease
M. Castro et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2007)
A meta-analysis of the placebo rates of remission and response in clinical trials of active ulcerative colitis
Chinyu Su et al.
GASTROENTEROLOGY (2007)
Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry
GR Lichtenstein et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Safety of low dose glucocorticoid treatment in rheumatoid arthritis:: published evidence and prospective trial data
JAP Da Silva et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities
SB Hanauer
INFLAMMATORY BOWEL DISEASES (2006)
Infliximab for induction and maintenance therapy for ulcerative colitis
P Rutgeerts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Erythrocytes-mediated delivery of dexamethasone in steroid-dependent IBD patients - A pilot uncontrolled study
V Annese et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Low doses of dexamethasone constantly delivered by autologous erythrocytes slow the progression of lung disease in cystic fibrosis patients
L Rossi et al.
BLOOD CELLS MOLECULES AND DISEASES (2004)
Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides
M Magnani et al.
GENE THERAPY (2002)
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study
WA Faubion et al.
GASTROENTEROLOGY (2001)
Erythrocyte-mediated delivery of dexamethasone in patients with chronic obstructive pulmonary disease
L Rossi et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2001)
Share Paper
